Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • Pediatric mesothelioma- A disease of a kind

Study of recovered COVID-19 patients with repeated positive RT-PCR findings in Wuhan, China

Cancer Vaccines: A Concoction Strategy to fight Leukemia

Pediatric mesothelioma- A disease of a kind
  • BiotechToday
  • World

Pediatric mesothelioma- A disease of a kind

bioxone October 15, 2020October 15, 2020

Sashreek Ganguli, Amity University Kolkata

Mesothelioma is a tumour caused by intake of asbestos fibers and forms within the peritoneum of lungs. The occurrence rate is high in people belonging to the age bracket of 80-84 years. To treat this, pemetrexed-based regimen with cytoreductive surgery (CRS) could be a commonly used, but long-term survival is rare with lifespan up to 12-21months, after diagnosis.

Apart from the adults, the paediatric population is simultaneously affected by the condition. Here it’s imperative to say that little was known about the characteristics of mesothelial tumors within the pediatric population. Hence, to further the knowledge on the condition in adolescents, scientists at the European Cooperative Study Group on Pediatric Rare Tumors (EXPeRT) reviewed past paediatric cases(1987-2018). They identified 33 patients and discovered the first tumour mainly within the peritoneum (23 patients).

The histology was multicystic mesothelioma in the peritoneum (MCM) (6 cases) or malignant mesothelioma (MM) (27 cases). There was documented evidence of exposure to asbestos in one case. Within, MM the response to permetrexed was 50% (i.e. 6/12) and survival rate to CRS-Hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) after a follow-up of 6.7 years (range, 0–20), five-year overall and event-free survivals were 82.3% (95% CI, confidential interval ((CI), 67.8–99.9) and 45.1% (95% CI, 28.4–71.7), respectively. In MCM, all patients survived after surgery and CRS-HIPEC. Conclusively, paediatric mesothelioma is different from its adult form with lesser asbestos exposures, more primary tumours in the peritoneum. The cisplatin–pemetrexed regimen showed good efficacy.

Also read: Covid-19 affects Brain directly?- Study revealed

Source: https://doi.org/10.1016/j.ejca.2020.09.011

  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Adolescents Asbestos cancer CRS CRS-HIPEC EXPeRT lung malignancy Mesothelioma Paediatric Peritoneum

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Cancer Vaccines: A Concoction Strategy to fight Leukemia

bioxone October 15, 2020

Chitra Roy, University of Calcutta Leukemia is a malignancy of blood cells that starts to develop when the DNA of a single cell in the bone marrow mutates and fails to develop and function properly. These leukemia cells crowd out normal blood cells, making it difficult for the normal cells to do their job. Chronic […]

Leukemia

Related Post

  • BiotechToday
  • World

Is COVID-19, a bacterium, or a virus?

bioxone October 18, 2020October 18, 2020

Salapu Chandralekha, Amity University Kolkata What secret did the Italian doctors uncover to prove that the COVID-19 is a bacterium, not a virus as advocated by the WHO guidelines? Italy was one of the European Nation’s which bore the brunt of COVID-19 pandemic accounting for over for 7.2% of deaths recorded across the Globe with […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Human Papillomavirus: Toxic Agent to Drive Cervical Cancer

BioTech Today July 24, 2021July 23, 2021

Saptaparna Dasgupta, Bennett University According to reported statistics, cervical cancer stands to be the fourth most frequent cancer amongst women all over the world. Human papillomavirus (HPV) acts as the devastating toxic agent that drives cervical cancer.  A study conducted in Tehran University of Medical Sciences involved five different variants of HPV amongst Iranian women […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Monitoring Brainwaves: Early Drug Non-Response detection can revolutionize the treatment of Depression

bioxone September 17, 2020September 17, 2020

–Sampriti Roy, Asutosh College The 21st-century treatment of depression involving psychotherapy and eclectic approaches has undoubtedly come a long way from earlier methods (like lobotomies). However, the standard treatment of MDD (Major Depression Disorder) today with antidepressants- normally SSRIs (Selective Serotonin Reuptake Inhibitors) can take around 4 weeks to months to show response-a duration that’s […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy